- Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
-
Seo KI, Yun BC, Li WJ, Lee SU, Han BH, Park ET
- KMID: 2412117
- Clin Mol Hepatol.
- 2017 Mar;23(1):74-79.
- doi: 10.3350/cmh.2016.0052
BACKGROUND/AIMS: Interferon-based treatment is not appropriate for a large number of patients with chronic hepatitis C for various medical and social reasons. Newly developed directly acting antivirals (DAAs) have been... -
- CITED
-
- Close
- SHARE
-
- Close
